After knockdown of ANXA1 in BLCA cells, EGFR signaling was significantly suppressed under both EGF-dependent and EGF-independent conditions, as well as downstream PI3K/AKT, MEK/ERK and JAK/STAT3 pathways. The gene discussed is MAP2K7; the disease is bladder transitional cell carcinoma.